Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Mar 31, 2010

Premium

Integrated Diagnostics, a personalized diagnostics company founded by Leroy Hood, announced the appointment of Albert Luderer as its first CEO. Luderer was previously president and CEO of BioTrove, a molecular biological tools company acquired by Life Technologies in December.

Before BioTrove, Luderer held leadership positions at several firms, including Light Sciences and bioMérieux. Luderer also had a hand in the creation of Siemens Diagnostics. He holds a PhD from Rutgers University where he was a National Science Foundation predoctoral fellow.

Integrated Diagnostics, raised $30 Million in Series A funding in September, is a newly formed company that uses genomic and proteomic techniques to personalize treatment by identifying blood proteins synthesized in the organ of interest.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.